Dazdotuftide is a small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication. The directory classifies it as a preclinical API with a biotechnology source/manufacturing origin. Other names for this substance include Dazdotuftida. Its PubChem CID is 163203622.
Dazdotuftide
| CAS No | 2522933-44-2 |
|---|---|
| Molecular Formula | C43H68N13O13P |
| Molecular Weight | 1006.1 g/mol |
| Synonyms | [4-[[5-[(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-2-carboxyethyl]-2-hydroxyphenyl]diazenyl]phenyl] 2-(trimethylazaniumyl)ethyl phosphate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dazdotuftide is a small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication. The directory classifies it as a preclinical API with a biotechnology source/manufacturing origin.
The listed CAS number is 2522933-44-2.
The listed molecular formula is C43H68N13O13P.
The listed molecular weight is 1006.1 g/mol.
[4-[[5-[(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-2-carboxyethyl]-2-hydroxyphenyl]diazenyl]phenyl] 2-(trimethylazaniumyl)ethyl phosphate.
The source lists Dazdotuftida.